Status:

UNKNOWN

Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

Lead Sponsor:

University of Guadalajara

Collaborating Sponsors:

National Council of Science and Technology, Mexico

Conditions:

Metabolic Syndrome

Eligibility:

All Genders

30-59 years

Phase:

PHASE2

Brief Summary

Metabolic syndrome (MetS) is a group of important cardiovascular risk factors: abdominal obesity, dyslipidemia, hyperglycemia, and high blood pressure. Treatment requires lifestyle changes and pharmac...

Detailed Description

INTRODUCTION: Ellagic acid (EA) is a polyphenol that has shown health benefits in multiple experimental studies; mainly as an antioxidant, but also in hepatic steatosis, endothelial damage, hypertensi...

Eligibility Criteria

Inclusion

  • Metabolic Syndrome diagnosis based on IDF criteria
  • Acceptance and signing of Informed Consent

Exclusion

  • Prior diagnosis of kidney, liver, pancreas, heart or thyroid disease
  • Diabetes mellitus or arterial hypertension
  • Alcoholism, drug abuse or tobacco use
  • Systolic blood pressure ≥140 mmHg
  • Diastolic blood pressure ≥90 mmHg
  • Fasting plasma glucose ≥126 mg/dL
  • TG ≥500 mg/dL
  • C-LDL \> 190 mg/dL
  • BMI: ≥35 kg/m2
  • Pregnancy (suspected or confirmed) or lactation
  • Menopausal period \<1 year
  • Hormonal contraceptive or replacement therapy
  • Known allergy to any of the interventions
  • Imposibility to shallow capsules
  • Pharmacological, dietary or herbal therapy in the last 3 months before trial
  • Weight variability above ±2.0 kg throughout the last 3 months before intervention

Key Trial Info

Start Date :

September 17 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2022

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT04011618

Start Date

September 17 2019

End Date

December 1 2022

Last Update

June 15 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universitario de Ciencias de la Salud

Guadalajara, Jalisco, Mexico, 44340